Viewing Study NCT02859350


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-21 @ 11:19 PM
Study NCT ID: NCT02859350
Status: COMPLETED
Last Update Posted: 2018-10-15
First Post: 2016-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Sponsor: Sanaria Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Plasmodium falciparum View
None PfSPZ Vaccine View
None PfSPZ Challenge (NF54) View
None CHMI View
None Chloroquine View
None Chemoprophylaxis View
None PfSPZ-CVac View